Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
开发 PF-06671008,一种具有延长半衰期的高效抗 P-钙粘蛋白/抗 CD3 双特异性 DART 分子,用于治疗癌症
期刊:Antibodies
影响因子:
doi:10.3390/antib5010006
Adam R Root, Wei Cao, Bilian Li, Peter LaPan, Caryl Meade, Jocelyn Sanford, Macy Jin, Cliona O'Sullivan, Emma Cummins, Matthew Lambert, Alfredo D Sheehan, Weijun Ma, Scott Gatto, Kelvin Kerns, Khetemenee Lam, Aaron M D'Antona, Lily Zhu, William A Brady, Susan Benard, Amy King, Tao He, Lisa Racie, Ma